Cracking The Code: Understanding Analyst Reviews For CollPlant Biotechnologies
Cracking The Code: Understanding Analyst Reviews For CollPlant Biotechnologies
破譯密碼:理解collplant生物技術的分析師評論
Throughout the last three months, 4 analysts have evaluated CollPlant Biotechnologies (NASDAQ:CLGN), offering a diverse set of opinions from bullish to bearish.
在過去的三個月裏,4位分析師對CollPlant Biotechnologies (NASDAQ:CLGN)進行了評估,提出了從看好到看淡的不同觀點。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中,您將找到他們最近的評級摘要,揭示了過去30天內情緒的變化,並將它們與前幾個月進行比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $12.5, along with a high estimate of $14.00 and a low estimate of $11.00. This current average reflects an increase of 4.17% from the previous average price target of $12.00.
總資產收益率(ROA):CollPlant生物技術的ROA低於行業平均水平,表明在高效利用資產方面存在挑戰。憑藉-13.02%的ROA,該公司可能在從資產中獲得最優回報方面面臨困難。
Deciphering Analyst Ratings: An In-Depth Analysis
分析師評級解讀:深入分析
登入免費觀看全文
登入/註冊